首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Preincubation of Pneumococci with β-Lactams Alone or Combined with Levofloxacin Prevents Quinolone-Induced Resistance without Increasing Intracellular Levels of Levofloxacin
【2h】

Preincubation of Pneumococci with β-Lactams Alone or Combined with Levofloxacin Prevents Quinolone-Induced Resistance without Increasing Intracellular Levels of Levofloxacin

机译:肺炎球菌与单独的β-内酰胺或与左氧氟沙星联用的预培养可在不增加氟西沙星细胞内水平的情况下防止喹诺酮诱导的耐药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Preincubation of pneumococci with sub-MIC concentrations of ceftriaxone (1/16× MIC), cefotaxime (1/8× MIC), and meropenem (1/4× MIC) alone or combined with levofloxacin (1/8× MIC) over 6 h prevents the emergence of levofloxacin-resistant mutants after 96 h of incubation but does not affect the intracellular accumulation of levofloxacin in two penicillin-resistant pneumococcal strains, suggesting a link between the mechanism of action of β-lactams and the emergence of quinolone-induced resistance in pneumococci.
机译:单独或与左氧氟沙星(1/8×MIC)联合使用低于MIC浓度的头孢曲松(1/16×MIC),头孢噻肟(1/8×MIC)和美罗培南(1/4×MIC)的肺炎球菌预培养孵育96 h后,h可阻止耐左氧氟沙星的突变体的出现,但不会影响左氧氟沙星在两种耐青霉素的肺炎球菌菌株中的细胞内蓄积,这表明β-内酰胺的作用机理与喹诺酮诱导的出现之间存在联系肺炎球菌耐药。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号